Deutsche Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $687M | Sell |
1,537,736
-231,145
| -13% | -$108M | 0.23% | 92 |
|
|
2025
Q4 | $802M | Buy |
1,768,881
+168,425
| +11% | +$72.6M | 0.26% | 79 |
|
|
2025
Q3 | $627M | Buy |
1,600,456
+192,822
| +14% | +$80.6M | 0.21% | 100 |
|
|
2025
Q2 | $627M | Buy |
1,407,634
+60,748
| +5% | +$28M | 0.23% | 92 |
|
|
2025
Q1 | $653M | Sell |
1,346,886
-42,719
| -3% | -$19.9M | 0.26% | 77 |
|
|
2024
Q4 | $560M | Buy |
1,389,605
+76,695
| +6% | +$35.6M | 0.22% | 92 |
|
|
2024
Q3 | $611M | Sell |
1,312,910
-66,410
| -5% | -$31.9M | 0.25% | 81 |
|
|
2024
Q2 | $647M | Sell |
1,379,320
-197,541
| -13% | -$85.7M | 0.29% | 66 |
|
|
2024
Q1 | $659M | Sell |
1,576,861
-69,804
| -4% | -$29.5M | 0.31% | 65 |
|
|
2023
Q4 | $670M | Buy |
1,646,665
+320,297
| +24% | +$118M | 0.34% | 58 |
|
|
2023
Q3 | $461M | Sell |
1,326,368
-270,232
| -17% | -$94.5M | 0.3% | 75 |
|
|
2023
Q2 | $562M | Sell |
1,596,600
-159,560
| -9% | -$53.8M | 0.3% | 75 |
|
|
2023
Q1 | $553M | Sell |
1,756,160
-96,922
| -5% | -$29.1M | 0.31% | 76 |
|
|
2022
Q4 | $535M | Buy |
1,853,082
+25,625
| +1% | +$7.81M | 0.31% | 76 |
|
|
2022
Q3 | $529M | Sell |
1,827,457
-213,715
| -10% | -$61.5M | 0.32% | 72 |
|
|
2022
Q2 | $575M | Sell |
2,041,172
-107,454
| -5% | -$28.8M | 0.32% | 68 |
|
|
2022
Q1 | $561M | Sell |
2,148,626
-410,687
| -16% | -$97.5M | 0.26% | 82 |
|
|
2021
Q4 | $562M | Sell |
2,559,313
-127,278
| -5% | -$24.7M | 0.25% | 84 |
|
|
2021
Q3 | $487M | Sell |
2,686,591
-47,319
| -2% | -$9.24M | 0.23% | 96 |
|
|
2021
Q2 | $551M | Buy |
2,733,910
+694,871
| +34% | +$145M | 0.27% | 80 |
|
|
2021
Q1 | $438M | Buy |
2,039,039
+783,218
| +62% | +$172M | 0.24% | 86 |
|
|
2020
Q4 | $297M | Buy |
1,255,821
+236,046
| +23% | +$54.2M | 0.18% | 116 |
|
|
2020
Q3 | $278M | Buy |
1,019,775
+116,703
| +13% | +$32.2M | 0.19% | 112 |
|
|
2020
Q2 | $262M | Sell |
903,072
-36,239
| -4% | -$9.83M | 0.2% | 104 |
|
|
2020
Q1 | $224M | Sell |
939,311
-532,686
| -36% | -$122M | 0.2% | 99 |
|
|
2019
Q4 | $322M | Sell |
1,471,997
-7,738
| -0.5% | -$1.57M | 0.21% | 93 |
|
|
2019
Q3 | $251M | Sell |
1,479,735
-320,786
| -18% | -$56.7M | 0.17% | 124 |
|
|
2019
Q2 | $330M | Buy |
1,800,521
+403,803
| +29% | +$70.6M | 0.19% | 101 |
|
|
2019
Q1 | $257M | Buy |
1,396,718
+432,709
| +45% | +$79.9M | 0.15% | 138 |
|
|
2018
Q4 | $160M | Sell |
964,009
-332,854
| -26% | -$57.7M | 0.11% | 184 |
|
|
2018
Q3 | $250M | Sell |
1,296,863
-84,362
| -6% | -$15M | 0.13% | 155 |
|
|
2018
Q2 | $235M | Buy |
1,381,225
+41,544
| +3% | +$6.44M | 0.12% | 174 |
|
|
2018
Q1 | $218M | Buy |
1,339,681
+407,204
| +44% | +$66.5M | 0.1% | 195 |
|
|
2017
Q4 | $140M | Sell |
932,477
-59,309
| -6% | -$8.78M | 0.09% | 240 |
|
|
2017
Q3 | $151M | Buy |
991,786
+205,898
| +26% | +$31M | 0.1% | 208 |
|
|
2017
Q2 | $101M | Sell |
785,888
-388,987
| -33% | -$46.8M | 0.07% | 308 |
|
|
2017
Q1 | $128M | Buy |
1,174,875
+40,805
| +4% | +$3.59M | 0.09% | 241 |
|
|
2016
Q4 | $83.5M | Sell |
1,134,070
-194,159
| -15% | -$15.8M | 0.07% | 331 |
|
|
2016
Q3 | $116M | Sell |
1,328,229
-54,153
| -4% | -$5.12M | 0.08% | 281 |
|
|
2016
Q2 | $119M | Buy |
1,382,382
+187,908
| +16% | +$16.2M | 0.08% | 279 |
|
|
2016
Q1 | $94.9M | Sell |
1,194,474
-102,111
| -8% | -$9.24M | 0.07% | 312 |
|
|
2015
Q4 | $163M | Buy |
1,296,585
+334,954
| +35% | +$40.4M | 0.11% | 203 |
|
|
2015
Q3 | $100M | Sell |
961,631
-206,384
| -18% | -$26.5M | 0.08% | 296 |
|
|
2015
Q2 | $144M | Buy |
1,168,015
+54,317
| +5% | +$6.84M | 0.09% | 259 |
|
|
2015
Q1 | $131M | Sell |
1,113,698
-67,699
| -6% | -$8.11M | 0.08% | 287 |
|
|
2014
Q4 | $140M | Sell |
1,181,397
-1,252,621
| -51% | -$141M | 0.09% | 278 |
|
|
2014
Q3 | $273M | Buy |
2,434,018
+233,581
| +11% | +$22.2M | 0.17% | 131 |
|
|
2014
Q2 | $208M | Sell |
2,200,437
-31,561
| -1% | -$2.21M | 0.14% | 170 |
|
|
2014
Q1 | $158M | Buy |
2,231,998
+825,842
| +59% | +$65.4M | 0.11% | 216 |
|
|
2013
Q4 | $104M | Sell |
1,406,156
-193,073
| -12% | -$13.4M | 0.08% | 297 |
|
|
2013
Q3 | $121M | Buy |
1,599,229
+521,804
| +48% | +$41.5M | 0.09% | 262 |
|
|
2013
Q2 | $86.3M | Buy |
+1,077,425
| New | +$79.3M | 0.07% | 314 |
|
Other funds holding VRTX
VCM
VPM
Deutsche Bank's VRTX Position: Q1 2026 in Review
Deutsche Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 13% in Q1 2026, selling an estimated $108M and leaving 1,537,736 shares worth $687M. The position accounts for 0.23% of the portfolio, ranked #92.
Deutsche Bank first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $802M in Q4 2025. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Deutsche Bank held 1,537,736 shares of Vertex Pharmaceuticals worth $687M as of Q1 2026.
- Deutsche Bank sold 231,145 Vertex Pharmaceuticals shares in Q1 2026, an estimated $108M.
- Vertex Pharmaceuticals made up 0.23% of Deutsche Bank's portfolio in Q1 2026, its #92 holding.
- Deutsche Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Vertex Pharmaceuticals position peaked at $802M in Q4 2025.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.